Catalyst
Slingshot members are tracking this event:
ZURAMPIC (lesinurad) approved by US FDA for patients with gout
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AZN |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 22, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Zurampic, Lesinurad, Xanthine Oxidase Inhibitor, Xoi, Hyperuricemia, Gout, Allopurinol, Febuxostat, Fda, Approval, Clear, Crystal
